Novo Nordisk planlægger at forsyne 50.000 huse med overskudsvarme gennem et nyt rørprojekt, der kan revolutionere grøn ...
Med skjulte lydoptagelser mener Ekstra Bladet nu at kunne trække tæppet væk under lokalt selskab, der systematisk udnytter ...
Virksomheden spiller en nøglerolle i den sag om mulig svindel og udnyttelse udenlandske arbejdere på Novo Nordisk-byggerier, som Ekstra Bladet har beskrevet de seneste dage.
Novo Nordisk is not the only company exploring ... in December 2021 to construct three new manufacturing facilities in Kalundborg, Denmark, that would cost the company $2.4 billion.
It will be part of the Danish diabetes API production organization in Kalundborg, which will be named DAPI-Denmark. Novo Nordisk announced in August 2015 that it would invest $2 billion in production ...
Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
New trial data showed the drug helped obese or overweight type 2 diabetics lose an average 15.7% of their weight, when an ...
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.
The Novo Nordisk Foundation and University of Copenhagen researchers have backtracked over a project to redefine how the world understands ultra-processed foods, after more than 90 independent food ...
Novo Nordisk stock was dropping on Wednesday after Roche said it had licensed a promising obesity drug in a deal that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback